Life Technologies Completes Investment in Synthetic Genomics, Inc.
Thursday, June 03, 2010 (110 reads)
CARLSBAD, Calif., Jun 02, 2010 (BUSINESS WIRE) --Life Technologies
Corporation (NASDAQ: LIFE), a provider of innovative life science
solutions, announced today that it has made an equity investment in
Synthetic Genomics, Inc. (SGI), a privately held company founded to
commercialize synthetic genomic advances. Terms of the investment were
not disclosed.
Read More |  |
|
|
|
Bioscience Funds May Signal Uptick
Saturday, May 29, 2010 (198 reads)
Friday, May 28, 2010 Portland Business Journal - by
Erik Siemers Business Journal staff writer
Veteran medical device entrepreneur Dick Sass is raising $20 million for a new venture capital fund designed to help bring promising medical device startups to market.
The effort coincides with another $10 million bioscience fund planned by Portland’s Reference Capital.
Combined, the two efforts seek to raise $30M.
Read More |  |
|
Bill Gates’ Cash Boosts Drug Company Schrodinger LLC
Sunday, May 23, 2010 (181 reads)
Friday, May 21, 2010 Portland Business Journal
- by Erik Siemers Business Journal
staff
writer
In Bill Gates, Schrodinger LLC believes it has the kind of deep-pocketed, patient investor necessary to develop its technology. The company, a developer of software used by pharmaceutical manufacturers and biotechnology labs, has received a $10 million investment from Cascade Investment LLC, Gates’ investment arm.
The capital is to be used solely for research and development of new technology.
Read More | |
|
Treasury Releases New Guidance For Tax Credit To Support Biomedical Research
Saturday, May 22, 2010 (115 reads)
WASHINGTON – The U.S. Department of the Treasury today
announced the guidelines for applying for the new Therapeutic Discovery
Project Program created by the Affordable Care Act. The program will
provide tax credits and grants to small firms that show significant
potential to produce new and cost-saving therapies, support good jobs
and increase U.S. competitiveness.
Read More | |
|
 |
|
|